恒指曾收复逾300点所有失地 港交所及蒙牛续升逾2%-3.5%屡破顶
本港2020年11月零售销售额按年跌幅进一步明显收窄至4%,优於市场预期降幅仅收窄至7.5%,但已连跌22个月。恒指继昨天反覆续升241点或近0.9%曾越27,500屡创逾十个月高後,今早在两大中资电讯股、中海油(00883.HK)、吉利(00175.HK)、阿里(09988.HK)及主席再度趁高抽水药明生物(02269.HK)低开逾3%拖累,低开191点或0.7%报27,281,跌幅曾扩至322点,低见27,150获承接,曾收复所有失地,高见27,473,现造27,422,仅回吐49点,成交额已达1,154亿元。
蓝筹股荣辱互见,美国持续打压中资企业,市场憧憬更多中概股回流香港上市及内地更多企业选择来港上市。港交所(00388.HK)连续第二天创纪录高,最高见455元,现造452.8元,续升2.5%,成交额已超过15.55亿元。
获花旗纳为今年内需股首选之一给予目标价55.05元的蒙牛(02319.HK)连续第四天创纪录高,最高见50.85元,现造49.55元,续升3.7%,成交增至1,372万股,涉资6.82亿元。此外,万洲(00288.HK)及恒安(01044.HK)也升逾3%,分别报6.94元及57.75元。
外电报道,纽交所不再将三大中资电讯股ADR除牌,联通(00762.HK)、中电信(00728.HK)及中移动(00941.HK)今早跟随ADR低开逾3%後,曾倒升7.5%-11%,其後升幅收窄至逾5.5%-7.5%,分别报4.81元、2.2元及46.25元。
相反,昨天破顶的友邦(01299.HK)、银娱(00027.HK)、中生(01177.HK)、药明生物、阿里、碧桂园(02007.HK)及中海外(00688.HK)跌逾2%-3.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.